Annexon Inc
Veridion Score
Composite trend over time
Why is ANNX moving today?
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ANNX.
ANNX insider activity
Annexon Inc
3 insiders bought in the last 90 days
Net buying: $12.1M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | 2026-06-11 | Yednock Ted | Insider | buy | $1.85 | 30,646 | 184,807 | $57K | SEC Form 4 |
| 2026-05-29 | 2026-05-28 | Satter Muneer A | Insider | buy | $5.41 | 613,497 | 10,342,134 | $3.3M | SEC Form 4 |
| 2026-05-13 | 2026-05-11 | Carson William H. | Insider | buy | $5.78 | 8,000 | 78,405 | $46K | SEC Form 4 |
| 2026-04-14 | 2026-04-10 | Carson William H. | Insider | buy | $6.20 | 8,000 | 70,405 | $50K | SEC Form 4 |
| 2026-03-12 | 2026-03-10 | Carson William H. | Insider | buy | $5.67 | 8,000 | 62,405 | $45K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 26 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moANNX contract awards, year to date.
Public federal awards linked to this ticker.
ANNX lobbying filings, year to date.
Registered lobbying filings matched to Annexon Inc.